ARA 290, a Nonerythropoietic Peptide Engineered from Erythropoietin, Improves Metabolic Control and Neuropathic Symptoms in Patients with Type 2 DiabetesMichael Brines, Albert Dahan, Rayaz A. Malik et al.|Molecular Medicine|2014Cited by 143
ARA 290 Improves Symptoms in Patients with Sarcoidosis-Associated Small Nerve Fiber Loss and Increases Corneal Nerve Fiber DensityAlbert Dahan, Michael Brines, Ann Dunne et al.|Molecular Medicine|2013Cited by 94
Corneal nerve quantification predicts the severity of symptoms in sarcoidosis patients with painful neuropathyMichael Brines, Anthony Cerami, Maarten Swartjes et al.|TECHNOLOGY|2013Cited by 19
Erratum to: ARA 290 Improves Symptoms in Patients with Sarcoidosis-Associated Small Nerve Fiber Loss and Increases Corneal Nerve Fiber DensityAlbert Dahan, Michael Brines, Ann Dunne et al.|Molecular Medicine|2016Cited by 0